Sirio Pharma (300791.SZ) issued 1.511 million restricted shares at a grant price of 13.27 yuan per share.
Xianle Health (300791.SZ) Announcement: On February 24th, 2025, the company issued restricted shares for the year 2025...
Sirio Pharma (300791.SZ) announced that on February 24, 2025, the company granted 1.511 million restricted stocks to the beneficiaries of the 2025 Restricted Stock Incentive Plan for the first time, with a grant price of 13.27 yuan per share.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
